'Class effect' amongst cardiac drugs: term of convenience or pharmacological reality?

被引：2

作者：

Krum, H ^{[1
]}

Ruschitzka, F

机构：

[1] Monash Univ, NHMRC Ctr Clin Res Excellence Therapeut, Melbourne, Vic, Australia

[2] Univ Hosp, Dept Cardiol, Zurich, Switzerland

来源：

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE | 2006年 / 60卷 / 01期

关键词：

D O I：

10.1111/j.1368-5031.2005.0787b.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2 / 5

页数：4

共 21 条

[1] Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial [J].

Bresalier, RS ;

Sandler, RS ;

Quan, H ;

Bolognese, JA ;

Oxenius, B ;

Horgan, K ;

Lines, C ;

Riddell, R ;

Morton, D ;

Lanas, A ;

Konstam, MA ;

Baron, JA .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (11) :1092-1102

[2] Selective COX-2 inhibition improves endothelial function in coronary artery disease [J].

Chenevard, R ;

Hürlimann, D ;

Béchir, M ;

Enseleit, F ;

Spieker, L ;

Hermann, M ;

Riesen, W ;

Gay, S ;

Gay, RE ;

Neidhart, M ;

Michel, B ;

Lüscher, TF ;

Noll, G ;

Ruschitzka, F .

CIRCULATION, 2003, 107 (03) :405-409

[3] Should evidence-based proof of drug efficacy be extrapolated to a "class of agents"? [J].

Furberg, CD ;

Psaty, BM .

CIRCULATION, 2003, 108 (21) :2608-2610

[4] Are all angiotensin-converting enzyme inhibitors interchangeable? [J].

Furberg, CD ;

Pitt, B .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (05) :1456-1460

[5] Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects [J].

Gainer, JV ;

Morrow, JD ;

Loveland, A ;

King, DJ ;

Brown, NJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (18) :1285-1292

[6]

Hatch M, 1996, J PHARMACOL EXP THER, V276, P187

[7] Differential effects of selective cyclooxygenase-2 inhibitors on endothelial function in salt-induced hypertension [J].

Hermann, M ;

Camici, G ;

Fratton, A ;

Hurlimann, D ;

Tanner, FC ;

Hellermann, JP ;

Fiedler, M ;

Thiery, J ;

Neidhart, M ;

Gay, RE ;

Gay, S ;

Lüscher, TF ;

Ruschitzka, F .

CIRCULATION, 2003, 108 (19) :2308-2311

[8]

Hjalmarson Å, 1999, LANCET, V353, P2001

[9]

Krum Henry, 2004, Expert Rev Cardiovasc Ther, V2, P265, DOI 10.1586/14779072.2.2.265

[10]

Lechat P, 1999, LANCET, V353, P9

← 1 2 3 →